Peer Re­view: aTyr pro­motes da­ta ex­pert San­jay Shuk­la as CEO

A guy with a pen­chant for tech and da­ta will be tak­ing the reins of San Diego pub­lic biotech aTyr Phar­ma $LIFE as the com­pa­ny’s for­mer CEO John Mendlein steps down.

The new chief ex­ec­u­tive and pres­i­dent is San­jay Shuk­la, a physi­cian and clin­i­cal de­vel­op­ment ex­pert who’s been serv­ing as aTyr’s chief med­ical of­fi­cer since March 2016. This will be Shuk­la’s first gig as CEO of a biotech, but he be­lieves his da­ta-crunch­ing back­ground makes him well-pre­pared for the job.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER